Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source-heavy congressional process material lives here so the main bill summary can stay focused. Use this tab for committee scheduling, hearings, CRS analysis, committee publications, and amendment text.
Nonpartisan Congressional Research Service analysis linked directly to this bill.
Nonpartisan background and policy analysis tied directly to this bill.
Introduction Between 2017 and 2022, spending on drugs dispensed outside of retail settings grew nationally at an annual rate of 9.4%, outpacing the 6.5% annual growth in spending on drugs in retail settings, such as retail pharmacies. The Medicare program covers these nonretail drugs, such as novel oncology and immuno…
Scheduled or recent committee meetings that mention this bill, plus agenda materials and witness documents.
No committee meetings linked to this bill yet.
Hearings, transcripts, and related meeting references associated with this bill.
No hearings linked to this bill yet.
Formal committee rationale and report language published for this bill.
No committee reports linked to this bill yet.
Working packets, committee print materials, and related draft text.
No committee prints linked to this bill yet.
Structured amendment records, latest actions, vote references, and text links.
No amendments linked to this bill yet.